SECsense Logo

Solid Biosciences Inc. 8-K Report: Key Insights for Investors on February 18, 2025

$SLDB
Form 8-K
Filed on: 2025-02-18
Source
Solid Biosciences Inc. 8-K Report: Key Insights for Investors on February 18, 2025

Based on the provided section of the financial report, here are the key insights and important information extracted:

  1. Entity Information:
  • Company Name: Solid Biosciences Inc.
  • CIK Number: 0001707502
  • SEC File Number: 001-38360
  • EIN: 90-0943402
  • Address: 500 Rutherford Avenue, Third Floor, Charlestown, MA 02129
  • Phone Number: (617) 337-4680
  1. Filing Information:
  • Filing Type: 8-K (a report of unscheduled material events or corporate changes)
  • Filing Date: February 18, 2025
  1. Financial Instrument:
  • Type of Stock: Common Stock
  • Par Value: $0.001 per share
  • Ticker Symbol: SLDB
  • Exchange: NASDAQ
  1. Reporting Period:
  • Period Start Date: February 18, 2025
  • Period End Date: February 18, 2025
  • This indicates a single day reporting period, which is typical for an 8-K filing that reports a specific event.
  1. XML Structure:
  • The document is structured in XBRL (eXtensible Business Reporting Language), which is used for the electronic communication of business and financial data.
  1. Namespace References:
  • The document includes namespaces for XBRL, DEI (Data Element Identifier), and linkbase, which are standard for SEC filings.

Insights:

  • The filing appears to be focused on a specific event or development concerning Solid Biosciences Inc. on the reporting date, which may have material implications for investors.
  • The use of an 8-K filing suggests that the information being reported is significant enough to warrant immediate disclosure to the public.
  • Given that the report is for a single day, it is crucial to look for the specific events or announcements that were made public on that date, as they could impact stock performance and investor decisions.

Further analysis would require access to the detailed content of the 8-K report to understand the nature of the disclosed event and its potential implications for the company and its stock.